MEN 10208 is a neurokinin A antagonist prepared by solid phase synthesis. The Fmoc strategy has more advantages than the Boc strategy in its preparation, and can obtain products with higher yield and purity.
References
[1] Solid-phase synthesis of neurokinin A antagonists. Comparison of the Boc and Fmoc methods PMID:1850390
